Insider Transactions in Q1 2021 at Akero Therapeutics, Inc. (AKRO)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 01
2021
|
Jonathan Young Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
3,055
-0.87%
|
$91,650
$30.8 P/Share
|
|
Feb 01
2021
|
Jonathan Young Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
3,055
-0.85%
|
$88,595
$29.56 P/Share
|
|
Jan 10
2021
|
Andrew Cheng President and CEO |
SELL
Open market or private sale
|
Direct |
10,000
-3.24%
|
$190,000
$19.55 P/Share
|
|
Jan 08
2021
|
Jonathan Young Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
10,000
-5.28%
|
$280,000
$28.12 P/Share
|
|
Jan 07
2021
|
Jonathan Young Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+3.81%
|
$0
$0.62 P/Share
|
|
Jan 07
2021
|
Andrew Cheng President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+5.22%
|
$0
$0.62 P/Share
|
|
Jan 04
2021
|
Jonathan Young Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
3,060
-0.83%
|
$76,500
$25.64 P/Share
|